4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-21-013754
Options or other derivatives
- Chief Financial Officer acquired 390,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Levine James E. Chief Financial Officer | 2021-07-12 | Grant or award · Common Stock | +390,000 | 390,000 | D | ||
Loading xslF345X03/wf-form4_162612095825628.xml…